Research Analysts Offer Predictions for ARWR Q2 Earnings
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities researchers at Leerink Partnrs increased their Q2 2025 earnings per share estimates for shares of Arrowhead Pharmaceuticals in a note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst M. Foroohar now expects that the biotechnology company will post earnings of ($0.32) per share for […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities researchers at Leerink Partnrs increased their Q2 2025 earnings per share estimates for shares of Arrowhead Pharmaceuticals in a note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst M. Foroohar now expects that the biotechnology company will post earnings of ($0.32) per share for […]
